As previously reported, Wedbush initiated coverage of Wave Life Sciences (WVE) with an Outperform rating and $18 price target Wave stands out ...

Genomic Testing Cooperative (GTC) today announced it received UKCA marks for its Hematology Profile Plus, Solid Tumor Plus as ...

A study in Ontario found no traces of influenza A viral ribonucleic acid (RNA) in 117 samples of pasteurized retail milk collected in April and May 2024, ...

Researchers from Agency for Science, Technology and Research in Singapore recently published a review article exploring how ...

RNA epigenetic modifications have uncovered as not only an intermediary structure between DNA and protein or an effector ...

A blood test can accurately predict whether someone without a known risk of preeclampsia is likely to develop the potentially ...

Our bodies are replete with bacteria and other microorganisms that coexist without harming us, but we do occasionally suffer ...

An in-depth look at Hepatitis D, why it’s so severe, and how new therapies bring hope for better treatment and prevention.

Concern is growing among public health experts that anti-vaccine sentiments within federal and state governments may derail ...

Oral presentation on April 13, 2025, highlighting positive BV100 Phase 2 VABP trial read-out with excellent efficacy and safety dataComplementary poster presentations featuring clinical & preclinical ...

Abstract The measurement of respiratory viruses in indoor air is critical for effectively preventing the spread of diseases. This is typically ...

Phase 2b study completed in amyotrophic lateral sclerosis (ALS) demonstrated lead asset PrimeC slows disease progression and functional decline Ongoing partnership ...